Company intelligence / Profile preview

ImagineRx

Ownership: Private
Development stage: Other

Overview

ImagineRx is a private biotechnology company developing a targeted drug-delivery platform for glioblastoma. Publicly available descriptions indicate the company is focused on a system designed to identify glioblastoma tumor cells and deliver anti-tumor drugs directly to them. The company has appeared in biosciences accelerator and startup-founder directories rather than in clinical trial or commercial product databases, suggesting it remains at an early development stage. Based on the limited disclosed information, ImagineRx appears to be a platform-oriented oncology startup centered on brain cancer drug delivery rather than a multi-asset clinical-stage therapeutics company.

Therapeutic areas: Oncology
Modalities: Drug delivery therapy
Industry: Biotech

Beyond the preview

Go deeper on ImagineRx.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on ImagineRx.

Explore the full profile